Kirurgisk behandling af cancer pancreatis

Magnus Bergenfeldt, Carsten Palnaes Hansen, Michael Bau Mortensen

4 Citationer (Scopus)


Surgery remains the only hope for cure in pancreatic cancer. The most common procedures are reviewed. Postoperative morbidity and mortality below 30% and 5%, respectively, are the standard. The benefit of extended lymph node dissection and portal-mesenteric vein resection is dubious. Selected patients with locally advanced cancer may be down-staged with chemo-radiotherapy and eventually resected. Endoscopic stent placement is the preferred method to relieve biliary and/or gastrointestinal obstruction. The outcome is better for patients treated at high-volume centres than at smaller hospitals.
Bidragets oversatte titel[Surgical treatment of pancreatic cancer]
TidsskriftUgeskrift for Laeger
Udgave nummer18
Sider (fra-til)1358-60
Antal sider3
StatusUdgivet - 3 maj 2010


Dyk ned i forskningsemnerne om 'Kirurgisk behandling af cancer pancreatis'. Sammen danner de et unikt fingeraftryk.